RDY
Dr. Reddy’s Laboratories Ltd
12.50$
+2.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.9% | 26.7% | 15.3% | 12.7% | 18.7% | 17.1% | 1,397.0% | 13.1% | 23.9% | 16.3% | 14.3% | 16.0% | |
| 5.5% | 6.6% | 8.0% | 8.2% | 7.9% | 7.1% | 500.7% | 5.5% | 5.1% | 5.3% | 5.2% | 6.1% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 22.9% | 0.3% | 0.2% | 0.1% | 0.1% | 0.1% | |
| 0.0% | 7.2% | 2.5% | -0.1% | -2.7% | 3.1% | 471.3% | 3.1% | – | – | – | – | |
| -10.1% | -0.1% | -3.8% | -6.3% | -3.8% | -4.3% | -324.3% | -6.5% | -3.2% | -7.2% | -9.2% | -3.5% | |
| 10.3% | 9.6% | 29.1% | 7.8% | 4.9% | 3.5% | 491.5% | 8.9% | 7.7% | 9.8% | 10.6% | 6.9% | |
| -15.5% | -13.2% | -13.1% | -10.5% | -5.0% | -2.8% | -886.6% | -12.3% | -16.8% | -14.4% | -17.8% | -20.0% | |
| 2.1% | 2.7% | 2.4% | 2.8% | 2.6% | 2.2% | 162.3% | 1.9% | 2.0% | 2.4% | 2.0% | 2.0% | |
| 2.0% | 0.0% | -11.1% | 0.0% | -0.3% | -0.3% | -46.7% | 0.2% | 0.1% | 0.3% | -0.4% | 0.0% | |
| 0.0% | -7.7% | 11.6% | 0.6% | -9.9% | -11.0% | 238.4% | 1.3% | -8.3% | 1.6% | 7.1% | 5.4% | |
| -2.8% | -11.0% | -2.6% | -3.1% | -13.9% | -14.4% | -11.7% | -1.1% | -10.9% | -1.3% | 5.8% | 3.8% | |
| -2.1% | -0.3% | -0.8% | -0.9% | -0.2% | -0.2% | 503.1% | 0.0% | -3.7% | 0.5% | 2.3% | -0.2% | |
| 6.5% | 17.0% | -13.8% | 4.9% | 13.8% | 13.6% | 905.5% | 4.2% | 16.3% | 6.4% | 3.7% | 9.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.